Huntington’s disease (HD) is a rare, inherited neurodegenerative disorder that progressively affects movement, cognition, and functional abilities. Despite advances in clinical research, there are currently no approved therapies demonstrated to slow or halt disease...
Glioblastoma (GBM) is one of the most aggressive malignant tumors of the central nervous system. Despite advances in cancer treatment, its standard approach—surgery when possible, followed by radiotherapy and chemotherapy—has remained largely unchanged for decades....
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells responsible for controlling voluntary muscle movement. While ALS has multiple genetic and non-genetic causes, approximately 1–2% of all ALS cases are associated...
Breast cancer has been one of the largest global threats to women's health for decades, with the American Cancer Society estimating nearly 297,790 new cases in U.S. women during 2023 alone. Recent developments in clinical research have highlighted the possibility...
While tuberculosis has been a threat to public health since the first half of the 19th century, it continues to be a public health priority that currently affects over 10 million people. In fact, tuberculosis was responsible for 1.6 million deaths in 2021 alone....
Throughout the history of vaccinology and drug safety, there have been innumerable adaptations and breakthroughs within the medication and vaccination development processes. However, since the very first inoculations of smallpox and measles, one clinical research and...